Reportlinker Adds 2008/2009 Healthcare Research Review

NEW YORK--(Business Wire)--
Reportlinker.com announces that a new market research report is available in its
catalogue.

Reportlinker Adds 2008/2009 Healthcare Research Review

http://www.reportlinker.com/p0128140/Reportlinker-Adds-2008/2009-Healthcare-Research-Review.html

Despite the global economic slowdown that began in 2008 and continues into 2009,
technology markets in healthcare and related industries remain strong. Companies
that provide technology products or related services to healthcare markets are
well-positioned to weather the current weak economy and be poised to take full
advantage of these growing markets when recovery arrives.

BCC Research has provided comprehensive coverage of healthcare technology
markets for many years, and we are now in the process of increasing our
production of healthcare-related technology market research reports. This review
of healthcare research conducted in 2008 and the first half of 2009 is meant to
provide a sampling of the type of quantitative market information, analysis, and
guidance that has been aiding business decision-making since BCC was founded in
1971.

This review includes highlights of reports published by BCC Research on the
following healthcare technology markets:

Medical Diagnostic Kits

Minimally Invasive Medical Devices

Cancer Therapies

The Dental Market

Organ and Tissue Transplantation and Alternatives

Disabled and Elderly Assistive Technologies

Medical Device Coatings

Pediatric Health Care Products and Services

We hope you find this Research Review valuable, and we look forward to serving
our customers` research needs in these growing healthcare markets.

Chapter-1: MEDICAL DIAGNOSTICS KITS

INTRODUCTION 1

STUDY GOALS AND OBJECTIVES 1

REASONS FOR DOING THE STUDY 1

INTENDED AUDIENCE 2

SCOPE OF REPORT 2

INFORMATION SOURCES 3

ANALYST CREDENTIALS 4

RELATED REPORTS 4

BCC ONLINE SERVICES 4

DISCLAIMER 4

SUMMARY 5

REPORT HIGHLIGHTS 6

TABLE 1 PROJECTED U.S. MDK MARKET BY END-USE SEGMENT, THROUGH 2013 ($ MILLIONS)
7

FIGURE 1 PROJECTED U.S. MDK MARKET BY END-USE SEGMENT, 2007-2013 ($ MILLIONS) 8

THE MDK INDUSTRY 8

WHAT ARE MDKS? 8

ADVANTAGES OF MDKS 9

USES FOR MDKS 10

Clinical Testing 10

Clinical Diagnostic Testing 10

Monitoring 10

Screening 11

Confirmatory Testing 11

Research 11

Home Use 11

Veterinary Diagnosis 11

MARKET SIZE 12

TABLE 2 PROJECTED U.S. MDK MARKET COMPARED WITH THE TOTAL DIAGNOSTIC TESTING
INDUSTRY, THROUGH 2013 ($ BILLIONS) 12

Relation to Total Testing Market 13

FIGURE 2 MDK`S RELATIVE SHARE OF U.S. TESTING MARKET PROJECTED, THROUGH 2013 ($
BILLIONS) 13

ALTERNATIVE METHODS 13

TABLE 3 ALTERNATIVE METHODS TO MDKS AND AREA OF PRIMARY USE 14

Chemical Assay 14

Culture 14

Microscopy 15

Biological Assay 15

Chromatographic Separation 15

MDK APPLICATIONS 16

TABLE 4 SELECTED MDK APPLICATIONS 16

INDUSTRY STRUCTURE 17

Reagents 17

Device/Carrier 17

Packaging 17

Component Suppliers 18

FIGURE 3 COMPONENTS OF AN MDK 18

TABLE 5 SELECTED LISTING OF MDK COMPONENT SUPPLIERS BY AREA OF PARTICIPATION 19

END MARKETS 19

TABLE 6 MDK APPLICATIONS BY END-USE FACILITY 20

Clinical Testing Facilities 20

TABLE 7 U.S. CLINICAL TESTING FACILITIES WITH POTENTIAL FOR USING MDKS: CLIA VS.
NON-CLIA 21

CLIA-Certified Laboratories 21

Non-CLIA Laboratories/Facilities 21

Research Laboratories 21

Home-Use Market 22

Veterinary Applications 22

TABLE 8 SELECTED LISTING OF ANIMAL TESTING MDKS 23

TRADE PRACTICES 23

Promotion 23

Pricing 24

Sales Tie-ins 24

Chapter-2: THE MARKET FOR MINIMALLY INVASIVE MEDICAL DEVICES

INTRODUCTION 25

MINIMALLY INVASIVE SURGERY 25

Minimally Invasive vs. Ambulatory Surgery 25

Minimally Invasive vs. Noninvasive Surgery 26

STUDY BACKGROUND 26

STUDY GOALS AND OBJECTIVES 27

INTENDED AUDIENCE 28

SCOPE OF REPORT 28

METHODOLOGY AND INFORMATION SOURCES 29

ANALYST CREDENTIALS 29

RELATED BCC RESEARCH STUDIES 30

SUMMARY 30

TABLE 9 GLOBAL MARKET FOR MIS DEVICES AND EQUIPMENT, THROUGH 2014 ($ BILLIONS)
31

FIGURE 4 GLOBAL MARKET FOR MIS DEVICES AND EQUIPMENT, 2007-2014 ($ BILLIONS) 31

GEOGRAPHIC SEGMENTS 32

TABLE 10 MARKET FOR MIS DEVICES AND EQUIPMENT SALES BY REGION, THROUGH 2014 ($
MILLIONS) 32

FIGURE 5 MAJOR MIS GEOGRAPHIC SEGMENTS, 2007 VS. 2014 (% OF TOTAL SALES) 33

END-USER SEGMENTS 33

TABLE11 U.S. MARKETS FOR MIS DEVICES AND EQUIPMENT SALES BY END-USER TYPE,
THROUGH 2014 ($ MILLIONS) 34

FIGURE 6 MAJOR U.S. MIS END-USER SEGMENTS, 2007 VS 2014 (% OF TOTAL SALES) 35

Chapter-3: CANCER THERAPIES: TECHNOLOGIES AND GLOBAL MARKETS

INTRODUCTION 36

STUDY OBJECTIVES 36

REASONS FOR DOING THIS STUDY 36

CONTRIBUTIONS OF THE STUDY AND FOR WHOM 37

SCOPE OF THE STUDY 37

METHODOLOGY 37

INFORMATION SOURCES 37

ABOUT THE AUTHOR 37

RELATED BCC REPORTS 38

SUMMARY 38

TABLE 12 THE GLOBAL CANCER THERAPY MARKET, THROUGH 2013 ($ MILLIONS) 38

FIGURE 7 THE GLOBAL CANCER THERAPY MARKET, 2006-2013 ($ MILLIONS) 39

REGULATORY ISSUES 40

NEW DRUG APPROVALS 40

TABLE 13 CANCER DRUGS APPROVED BY THE FDA 40

NEW DRUG APPLICATIONS 47

TABLE 14 NEW DRUG APPLICATIONS (2005 TO JANUARY 2008) 47

RECALLS 48

TABLE 15 RECALLS (2005 TO JANUARY 2008) 49

Chapter-4: THE DENTAL MARKET: TECHNIQUES, EQUIPMENT, AND MATERIALS

INTRODUCTION 52

STUDY GOALS AND OBJECTIVES 52

REASONS FOR DOING THE STUDY 52

SCOPE OF REPORT 52

METHODOLOGY 53

RELATED BCC STUDIES 53

ANALYST CREDENTIALS 53

SUMMARY 54

THE DENTAL MARKET: MAJOR MARKETS SUMMARY 54

TABLE 16 TOTAL U.S. DENTAL MARKET ANALYSIS BY PRODUCT SEGMENT, THROUGH 2013 ($
MILLIONS) 55

FIGURE 8 TOTAL U.S. DENTAL MARKET ANALYSIS BY PRODUCT SEGMENT, 2006-2013 ($
MILLIONS) 55

INDUSTRY OVERVIEW 56

STRUCTURE AND HISTORY OF THE DENTAL INDUSTRY 56

DESCRIPTIONS AND STATISTICS OF DENTAL PRACTICES 59

Endodontics 59

Orthodontics 60

Periodontics 60

Prosthodontics 61

Dental Offices 61

TABLE 17 DENTAL PROFESSIONALS BY YEAR, 1990-2005 (NUMBER) 62

Dental Laboratories 62

TECHNOLOGY 62

FUTURE OF DENTISTRY 62

DIGITAL INTRAORAL CAMERAS 63

REMINERALIZING AGENTS, FLUORIDE, AND BLEACHING PRODUCTS 64

PRACTICE MANAGEMENT SOFTWARE 64

DIGITAL AND 3D DIGITAL RADIOGRAPHY 64

SNAP-ON SMILE 65

LIGHT-ACTIVATED WHITENING SYSTEMS 66

AIR ABRASION 66

MINIMALLY INVASIVE TECHNIQUES 67

LASER CARIES DETECTION 67

COMPUTER-AIDED DRAFTING/COMPUTER AIDED MANUFACTURING (CAD/CAM) 67

PROFESSIONAL DENTAL EQUIPMENT AND SUPPLIES 68

OVERVIEW 68

DENTAL EQUIPMENT 68

Overview 68

Product Description 68

Dental Furniture 68

Operatory Units 69

TABLE 18 SELECTED MANUFACTURER AND DISTRIBUTOR LIST FOR GENERAL DENTAL FURNITURE
69

Cavity Preparation Systems and Air Abrasion Units 69

Dental Lasers 70

•Diode Laser 70

•CO2 Laser 71

•Erbium Laser 71

TABLE 19 SELECTED LIST OF DENTAL LASER MANUFACTURERS AND SUPPLIERS 71

Sterilizers and Autoclaves 72

TABLE 20 SELECTED DENTAL STERILIZER AND AUTOCLAVE SUPPLIERS 72

Amalgamators and Mixers 72

TABLE 21 SELECTED MANUFACTURERS AND DISTRIBUTORS OF AMALGAMATORS AND MIXERS 73

X-ray Devices and Related Equipment 73

•Digital Dental X-Ray Systems 73

•Film Processors 74

TABLE 22 SELECTED MANUFACTURERS AND DISTRIBUTORS OF DENTAL X-RAY DEVICES AND
EQUIPMENT 75

Other Types of Dental Equipment 75

•Intraoral Cameras 75

TABLE 23 SELECTED MANUFACTURERS AND DISTRIBUTORS OF INTRAORAL CAMERAS 76

•Air Compressors and Vacuum Systems 76

TABLE 24 SELECTED MANUFACTURERS AND DISTRIBUTORS OF AIR COMPRESSORS AND VACUUM
SYSTEMS 76

Nitrous Oxide Systems 77

TABLE 25 SELECTED MANUFACTURERS AND DISTRIBUTORS OF NITROUS OXIDE SYSTEMS 77

•Ultrasonic Cleaners 77

TABLE 26 SELECTED MANUFACTURERS AND DISTRIBUTORS OF ULTRASONIC CLEANERS 77

•Scalers 78

TABLE 27 SELECTED MANUFACTURERS AND DISTRIBUTORS OF DENTAL SCALERS 78

•Curing Lights 78

TABLE 28 SELECTED MANUFACTURERS AND DISTRIBUTORS OF CURING LIGHTS 78

•Laboratory Equipment 79

TABLE 29 SELECTED MANUFACTURERS AND DISTRIBUTORS OF LABORATORY EQUIPMENT 79

MARKET ANALYSIS 79

TABLE 30 MARKET FOR DENTAL EQUIPMENT BY PRODUCT SEGMENT, THROUGH 2013 ($
MILLIONS) 80

FIGURE 9 MARKET FOR DENTAL EQUIPMENT BY PRODUCT SEGMENT, 2006-2013 ($ MILLIONS)
80

Chapter-5: ORGAN AND TISSUE TRANSPLANTATION AND ALTERNATIVES

INTRODUCTION 81

STUDY GOAL AND OBJECTIVES 81

REASONS FOR DOING THE STUDY 81

INTENDED AUDIENCE 82

SCOPE OF REPORT 82

METHODOLOGY 82

INFORMATION SOURCES 83

AUTHOR`S CREDENTIALS 83

RELATED BCC PUBLICATIONS 83

SUMMARY 83

TABLE 31 U.S. MARKET FOR SOLID ORGAN AND TISSUE TRANSPLANTATION, THROUGH 2013 ($
MILLIONS) 85

FIGURE 10 U.S. MARKET FOR SOLID ORGAN AND TISSUE TRANSPLANTATION, 2007-2013 ($
MILLIONS) 85

INDUSTRY OVERVIEW 85

HISTORY OF TRANSPLANTATION 87

TISSUE TYPING 87

IMMUNOSUPPRESSION 87

Newer Immunosuppressive Drugs 88

PRESERVATION 89

GOVERNMENT REIMBURSEMENT 90

THE TRANSPLANTATION PROCESS 90

PREPARATION 90

SURGERY 91

RECUPERATION 91

MAINTENANCE 92

IMPORTANCE OF THE INDUSTRY 92

ORGANS 92

TABLE 32 U.S. ORGAN TRANSPLANTS: AVERAGE FIRST YEAR COST, NUMBER OF PROCEDURES
AND VALUE BY TYPE OF ORGAN TRANSPLANT, THROUGH 2013 ($ MILLIONS) 93

KIDNEY 93

TABLE 33 LEADING U.S. KIDNEY TRANSPLANT PROGRAMS BY TOTAL NUMBER OF PROCEDURES
PERFORMED IN 2007 94

LIVER 94

TABLE 34 TOP FIVE U.S. LIVER TRANSPLANT PROGRAMS BY TOTAL PROCEDURES PERFORMED
IN 2007 95

HEART 95

TABLE 35 TOP FIVE U.S. HEART TRANSPLANT PROGRAMS BY TOTAL PROCEDURES PERFORMED
IN 2007 96

LUNG 96

TABLE 36 TOP FIVE U.S. LUNG TRANSPLANT PROGRAMS BY TOTAL PROCEDURES PERFORMED IN
2007 96

INTESTINE 97

TABLE 37 TOP FIVE U.S. INTESTINE/SMALL BOWEL TRANSPLANT PROGRAMS BY TOTAL
PROCEDURES PERFORMED IN 2007 97

PANCREAS 97

TABLE 38 TOP FIVE U.S. PANCREAS TRANSPLANT PROGRAMS BY TOTAL PROCEDURES
PERFORMED IN 2007 98

TISSUES 98

DRIVERS IN THE MARKET 99

TABLE 39 TISSUE GRAFTING IN THE U.S. BY TISSUE TYPE, THROUGH 2013 (MILLION
PROCEDURES) 99

FIGURE 11 U.S. MARKET FOR TISSUE GRAFTING PROCEDURES BY TYPE, 2007-2013 (MILLION
PROCEDURES) 100

CORNEA 100

BLOOD STEM CELLS 101

BONE ALLOGRAFTS 101

HEART VALVES 101

VASCULAR TISSUE 102

SKIN AND COLLAGEN 102

Applications 102

WAITING LISTS OUTPACE DONATIONS 103

TABLE 40 PATIENTS ON U.S. WAITING LISTS AT THE END OF THE YEAR BY TYPE OF ORGAN
TRANSPLANT, 2003-2006 103

TRENDS IN U.S. LIVING AND CADAVERIC DONATIONS 104

TABLE 41 TRENDS IN U.S. LIVING AND CADAVERIC DONATIONS, THROUGH 2013 105

TRENDS IN TRANSPLANTATION OF ALL ORGANS 105

TABLE 42 U.S. ORGAN TRANSPLANTS, THROUGH 2006 (NUMBER OF PROCEDURES) 105

INTERNATIONAL TRENDS 106

TABLE 43 NUMBERS OF DONATED CADAVERS BY REGION, 2003-2006 106

LIMITED SUPPLY CURTAILS TRANSPLANTATIONS 106

Living Donor Programs 107

KEY FACTORS IN INDUSTRY GROWTH 107

Reducing Demand 107

Patient Survival Rates 108

TABLE 44 ONE-YEAR AND FIVE-YEAR PATIENT SURVIVAL RATES, BY ORGAN FOR TRANSPLANTS
PERFORMED, 1997-2004 (%) 108

TABLE 45 ONE-YEAR AND FIVE-YEAR GRAFT SURVIVAL RATES, BY ORGAN FOR TRANSPLANTS
PERFORMED, 1997-2004 (%) 108

TABLE 46 NUMBER OF PEOPLE IN THE U.S. LIVING WITH A FUNCTIONING TRANSPLANT BY
TYPE, 2000-2005* 109

Organ Substitutes 109

Organs from Animals: Xenotransplantation 109

Organ Primordia 110

Nuclear Transfer to Eliminate the Rejection Gene 110

Porcine Endogenous Retrovirus 111

ARTIFICIAL ORGANS 111

CELLULAR TRANSPLANTS 112

ORGAN REJECTION STRATEGIES 112

KEY FACTORS INHIBITING GROWTH 113

LACK OF DONORS 113

ALTERNATIVE THERAPIES 113

CULTURAL STIGMAS 113

Chapter-6: DISABLED AND ELDERLY ASSISTIVE TECHNOLOGIES IN THE U.S.

INTRODUCTION 114

ASSISTIVE TECHNOLOGY PRODUCTS 114

STUDY BACKGROUND 114

STUDY GOALS AND OBJECTIVES 115

INTENDED AUDIENCE 115

SCOPE OF REPORT 116

METHODOLOGY AND INFORMATION SOURCES 117

ANALYST CREDENTIALS 117

RELATED BCC RESEARCH REPORTS 117

SUMMARY 118

TABLE 47 PROJECTED U.S. ASSISTIVE TECHNOLOGY SALES, THROUGH 2013 ($ MILLIONS)
118

FIGURE 12 PROJECTED U.S. ASSISTIVE TECHNOLOGY SALES, 2007-2013 ($ MILLIONS) 119

INDUSTRY STRUCTURE AND COMPETITION 119

NUMBER AND SIZE OF FIRMS 119

MARKET SHARES 120

Mobility Aids 120

FIGURE 13 MOBILITY AIDS MARKET LEADERS, 2007 (%) 121

Access Aids 121

FIGURE 14 ACCESS AIDS MARKET LEADERS, 2007 (%) 122

Beds, Seating Systems, and Ergonomic Aids 122

FIGURE 15 BEDS, SEATING SYSTEMS, AND ERGONOMETRIC AIDS MARKET LEADERS, 2007 (%)
123

Daily Living Aids 123

FIGURE 16 DAILY LIVING AIDS MARKET LEADERS, 2007 (%) 124

Communication Aids 124

FIGURE 17 COMMUNICATION AIDS MARKET LEADERS, 2007 (%) 125

Computer Access Aids 125

FIGURE 18 COMPUTER ACCESS AIDS MARKET LEADERS, 2007 (%) 126

Vision and Reading Aids 127

FIGURE 19 VISION AND READING AIDS MARKET LEADERS, 2007 127

Environmental Aids 128

Medical/Personal Monitoring Aids 128

FIGURE 20 MEDICAL/PERSONAL MONITORING AIDS MARKET LEADERS, 2007 (%) 129

Chapter-7: MEDICAL DEVICE COATINGS

INTRODUCTION 130

STUDY GOAL AND OBJECTIVES 130

REASONS FOR DOING THE STUDY 130

INTENDED AUDIENCE 131

SCOPE OF REPORT 131

TWENTY-TWO MEDICAL SPECIALTIES 132

METHODOLOGY 134

INFORMATION SOURCES 134

ANALYST`S CREDENTIALS 135

RELATED BCC WORK CREDENTIALS 135

SUMMARY 135

TABLE 48 GLOBAL MEDICAL DEVICE COATING MARKET BY REGION, THROUGH 2014 ($
MILLIONS) 136

FIGURE 21 GLOBAL MEDICAL DEVICE COATING MARKET BY REGION, 2009 AND 2014 ($
MILLIONS) 137

Chapter-8: PEDIATRIC HEALTH CARE PRODUCTS AND SERVICES

INTRODUCTION 138

STUDY GOAL AND OBJECTIVES 138

REASONS FOR DOING THE STUDY 138

INTENDED AUDIENCE 139

SCOPE OF REPORT 139

INFORMATION SOURCES 139

ANALYST`S CREDENTIALS 140

RELATED BCC PUBLICATIONS 140

SUMMARY 140

PROJECTED GROWTH OF PEDIATRIC MARKETS 141

TABLE 49 GLOBAL TRENDS IN PEDIATRIC HEALTH CARE, THROUGH 2013 ($ MILLIONS) 141

FIGURE 22 GLOBAL TRENDS IN PEDIATRIC HEALTH CARE BASED ON CONDITION, 2007-2013
($ MILLIONS) 141

MARKET FORECASTS FOR SHORT-TERM ILLNESSES 142

Rotavirus 142

Ear Infections 142

Upper Respiratory Infections 142

MARKET FORECASTS FOR CHRONIC ILLNESSES 142

Allergies 143

Attention Deficit Disorders 143

Asthma 143

Autism Spectrum Disorders 144

Diabetes 144

Obesity 144

OVERVIEW OF THE PEDIATRIC HEALTHCARE INDUSTRY 145

TABLE 50 PROJECTED PEDIATRIC PREVENTATIVE CARE COSTS FROM BIRTH THROUGH AGE 18
IN THE U.S., THROUGH 2013 ($ MILLIONS) 145

PRENATAL CARE/IMPLICATIONS 145

International Prenatal Care/Implications 146

Low Birth Weight 146

NEWBORN CARE 147

Care in the U.S. 147

International Newborn Care 147

Malnutrition 148

CHILDREN AGE 1 TO 6 148

CHILDREN AGE 7 TO 12 149

ADOLESCENT CHILDREN AGE 13 TO 18 149

ADOLESCENT REPRODUCTIVE HEALTH 150

Sexually Transmitted Diseases 150

Human Papillomavirus (HPV) 150

VACCINES/IMMUNIZATIONS 151

TABLE 51 IMMUNIZATION SCHEDULE FOR CHILDREN FROM BIRTH TO 6 MONTHS 151

TABLE 52 IMMUNIZATION SCHEDULE FOR CHILDREN FROM 12 MONTHS TO 4 TO 6 YEARS 152

TABLE 53 IMMUNIZATION SCHEDULE FOR CHILDREN AND ADOLESCENTS FROM 7 TO 18 152

Vaccine Efficacy and Controversy 153

IMPLICATIONS FOR FUTURE DEVELOPMENTS IN THE U.S. 153

SHORT-TERM ILLNESSES IN THE PEDIATRIC POPULATION 154

TABLE 54 GLOBAL COSTS OF THREE PRIMARY SHORT-TERM ILLNESSES IN PEDIATRIC
POPULATION, THROUGH 2013 ($ MILLIONS) 155

FIGURE 23 GLOBAL COST OF PEDIATRIC SHORT-TERM ILLNESS, 2008 AND 2013 ($
MILLIONS) 155

OTITIS MEDIA (EAR INFECTIONS) 156

Causes of Otitis Media 156

Allergies 156

Infection 156

Blockage 157

Nutrition and Breastfeeding 157

Types and Symptoms 157

Treatment 158

Pharmacological Intervention 158

•Use of Prevnar 158

TABLE 55 GLOBAL PRESCRIPTION COSTS FOR TREATMENT OF PEDIATRIC OTITIS MEDIA,
THROUGH 2013 ($ MILLIONS) 159

TABLE 56 PRESCRIPTION COSTS FOR TREATMENT OF PEDIATRIC OTITIS MEDIA, IN THE
U.S., THROUGH 2013 ($ MILLIONS) 159

Surgical Intervention 160

•Myringotomy 160

TABLE 57 GLOBAL SURGICAL COSTS FOR MYRINGOTOMY IN PEDIATRIC PATIENTS, THROUGH
2013 ($ MILLIONS) 160

TABLE 58 SURGICAL COSTS FOR MYRINGOTOMY IN U.S. PEDIATRIC PATIENTS, THROUGH 2013
($ MILLIONS) 161

•Adenoidectomy and Tonsillectomy 161

TABLE 59 GLOBAL SURGICAL COSTS FOR TONSILLECTOMY/ADENOIDECTOMY IN PEDIATRIC
PATIENTS, THROUGH 2013 ($ MILLIONS) 163

TABLE 60 SURGICAL COSTS FOR TONSILLECTOMY/ADENOIDECTOMY IN U.S. PEDIATRIC
PATIENTS, THROUGH 2013 ($ MILLIONS) 163

GASTROINTESTINAL ILLNESSES 163

Rotavirus 164

Transmission 164

Symptoms 164

Treatment 164

•Dehydration 165

•Zinc 165

Vaccinations 165

•Rotateq 166

•Rotarix 166

TABLE 61 GLOBAL VACCINATION FOR PEDIATRIC ROTOVIRUS, THROUGH 2013 ($ MILLIONS)
166

TABLE 62 U.S. VACCINATION FOR PEDIATRIC ROTOVIRUS, THROUGH 2013 ($ MILLIONS) 166

Gastroesophageal Reflux 167

Treatment 167

•Eliminate Symptoms 167

•Heal Esophagus 168

•Prevent Complications 168

TABLE 63 CURRENT TREATMENTS FOR GERD 168

UPPER RESPIRATORY INFECTIONS 169

TABLE 64 GLOBAL DIRECT COSTS OF PEDIATRIC UPPER RESPIRATORY INFECTIONS, THROUGH
2013 ($ MILLIONS) 169

TABLE 65 DIRECT COSTS FOR PEDIATRIC UPPER RESPIRATORY INFECTIONS IN THE U.S,
THROUGH 2013 ($ MILLIONS) 170

Causes and Symptoms 170

TABLE 66 COMMON SYMPTOMS OF AN URI 171

Treatments 171

Increased Fluid Intake 171

Second-Hand Smoke 172

Medications 172

Antibiotic Treatments 172

Withdrawing Medicines 173

Complications 174

To order this report:

Reportlinker Adds 2008/2009 Healthcare Research Review

http://www.reportlinker.com/p0128140/Reportlinker-Adds-2008/2009-Healthcare-Research-Review.html

More market research reports here!

Reportlinker
Nicolas: nbo@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626

Copyright Business Wire 2009